JACINTA WANGUI: Open Payments
NPI 1447769880 · COLUMBUS CITY, IA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$185 in 9 payments from 5 companies in 2025. Trend: 2023 $250 · 2024 $276 · 2025 $185
Food & beverage: $185
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 4 | $86 |
| ABBVIE INC. | 2 | $49 |
| Otsuka America Pharmaceutical, Inc. | 1 | $22 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $14 |
| AstraZeneca Pharmaceuticals LP | 1 | $14 |
Products named: MOUNJARO, VRAYLAR, REXULTI, ZEPBOUND, CAPLYTA, FARXIGA.
Industry payments across IA — which companies pay providers there.
